Literature DB >> 28236552

Postoperative Impact of Diabetes, Chronic Kidney Disease, Hemodialysis, and Renal Transplant After Total Hip Arthroplasty.

Beau J Kildow1, Perez Agaba1, Brian F Moore1, Rhett K Hallows1, Michael P Bolognesi1, Thorsten M Seyler1.   

Abstract

BACKGROUND: The prevalence of diabetes mellitus (DM), chronic kidney disease (CKD), hemodialysis (HD), and renal transplantation (RT) is increasing. This study assessed postoperative complications among diabetic patients with CKD, HD, or post-RT after total hip arthroplasty (THA).
METHODS: Four cohorts were created using a nationwide database: DM&THA, DM&CKD&THA, DM&HD&THA, and DM&RT&THA. Cohorts were matched to a control group by age and gender. Thirty-day medical complications and 90-day and 2-year surgical complications were evaluated.
RESULTS: All 30-day complications were higher in each cohort. Ninety-day and 2-year surgical complications in the DM&HD&THA cohort were increased compared to the DM&RT&THA cohort. Remarkably, no increased risk of periprosthetic joint infection, periprosthetic fracture, or revision was noted post-THA in the DM&RT&THA cohort.
CONCLUSION: Diabetic patients with worsening kidney function are associated with increased post-THA complications. Postsurgical risks decline following RT. Diabetic patients with kidney failure may want to undergo RT prior to THA to optimize surgical outcomes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; diabetes; hemodialysis; renal transplantation; total hip arthroplasty

Mesh:

Year:  2017        PMID: 28236552     DOI: 10.1016/j.arth.2017.01.018

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  8 in total

1.  Comparison of total joint arthroplasty outcomes between renal transplant patients and dialysis patients-a meta-analysis and systematic review.

Authors:  Jiayi Li; Mingyang Li; Bo-Qiang Peng; Rong Luo; Quan Chen; Xin Huang
Journal:  J Orthop Surg Res       Date:  2020-12-09       Impact factor: 2.359

2.  Factors associating with surgical site infection following operative management of malleolar fractures at an urban level 1 trauma center.

Authors:  Alexander S Rascoe; Michael D Kavanagh; Megan A Audet; Emily Hu; Heather A Vallier
Journal:  OTA Int       Date:  2020-05-06

3.  Comprehensive geriatric assessment for older orthopedic patients and analysis of risk factors for postoperative complications.

Authors:  Chao Kong; Yanhong Zhang; Chaodong Wang; Peng Wang; Xiangyu Li; Wei Wang; Yu Wang; Jianghua Shen; Xiaoyi Ren; Tianlong Wang; Guoguang Zhao; Shibao Lu
Journal:  BMC Geriatr       Date:  2022-08-04       Impact factor: 4.070

4.  Development and validation of a nomogram to predict complications in patients undergoing simultaneous bilateral total knee arthroplasty: A retrospective study from two centers.

Authors:  Kuishuai Xu; Liang Zhang; Zhongkai Ren; Tianrui Wang; Yingze Zhang; Xia Zhao; Tengbo Yu
Journal:  Front Surg       Date:  2022-09-14

5.  Impact of comorbid conditions on outcomes of hip and knee replacement surgery: a systematic review and meta-analysis.

Authors:  Bélène Podmore; Andrew Hutchings; Jan van der Meulen; Ajay Aggarwal; Sujith Konan
Journal:  BMJ Open       Date:  2018-07-11       Impact factor: 2.692

6.  Primary Total Hip Arthroplasty in Hispanic/Latino Patients: An Updated Nationwide Analysis of Length of Stay, 30-Day Outcomes, and Risk Factors.

Authors:  Christian Gronbeck; Antonio Cusano; Justin M Cardenas; Melvyn A Harrington; Mohamad J Halawi
Journal:  Arthroplast Today       Date:  2020-08-27

7.  Failure to Medically Optimize Before Total Hip Arthroplasty: Which Modifiable Risk Factor Is the Most Dangerous?

Authors:  Joseph M Statz; Susan M Odum; Nicholas R Johnson; Jesse E Otero
Journal:  Arthroplast Today       Date:  2021-07-05

8.  Effect of renal dialysis on mortality and complications following hip fracture surgery in elderly patients: A population based retrospective cohort study.

Authors:  Eun-Jin Ahn; Si Ra Bang
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.